Literature DB >> 12217618

Treatment of advanced stage patients with Parkinson's disease.

Cheryl H Waters1.   

Abstract

Most patients with Parkinson's disease (PD) receiving chronic levodopa therapy eventually manifest one or more motor response complications, including 'wearing-off' phenomena and on-off phenomena. Additionally, as the disease progresses, motor, neurologic, and neuropsychiatric complications increase and may include freezing spells, falls, dementia, depression and psychosis. The management of patients with advanced PD presents a special clinical challenge because patients may experience an enhanced sensitivity to small changes in plasma levodopa levels and because they may suffer adverse reactions to antiparkinsonian drugs. Management of advanced PD is directed toward decreasing the dose of the offending drug while raising the dose of alternative drug with the goal of maintaining symptom control. In this article, the spectrum of late complications experienced by patients with advanced PD and their management are discussed. Copyright 2002 Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217618     DOI: 10.1016/s1353-8020(02)00040-8

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Shortness of breath, a 'wearing-off' symptom in Parkinson's disease.

Authors:  Waqas Khan; Sughra Naz; Abdul Qayyum Rana
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 2.  Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.

Authors:  Jack J Chen; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Parkinson's disease permanent care unit: managing the chronic-palliative interface.

Authors:  Johan Lökk
Journal:  J Multidiscip Healthc       Date:  2011-04-01

4.  Motor fluctuations and dyskinesias (diagnosis and management).

Authors: 
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

5.  Slurring of Speech and Lip Paresthesia: Symptoms of Levodopa End of Dose Wearing Off in Parkinson's Disease.

Authors:  Usama Nasir; Muhammad Ali Tariq; Asad Ali; Syed Daniyal Asad; Ahmer Asif; Fnu Farukhuddin; Rovaid Khan; Haris H Chaudhry; Sarah Choudry
Journal:  Cureus       Date:  2018-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.